Literature DB >> 12473759

The incremental direct costs associated with behavioral symptoms in AD.

D L Murman1, Q Chen, M C Powell, S B Kuo, C J Bradley, C C Colenda.   

Abstract

OBJECTIVE: To determine the incremental costs associated with behavioral symptoms in patients with AD.
METHODS: A total of 128 patients with probable AD were enrolled into this study. Cognitive function and extrapyramidal features were assessed in patients with AD. Caregivers were interviewed to determine use of health care services, receipt of unpaid care, severity of behavioral symptoms (Neuropsychiatric Inventory [NPI]), and comorbid medical conditions in patients with AD. Healthcare utilization data were multiplied by unit costs to estimate direct formal costs. Unpaid caregiving hours were multiplied by an hourly wage to estimate direct informal costs. The annual incremental direct costs of additional behavioral symptoms were estimated with multiple regression equations.
RESULTS: Annual, direct costs were significantly higher in patients with AD at or above the median score on the NPI (high NPI group), after adjusting for group differences in severity of cognitive impairment and comorbid conditions. Patients in the high NPI group had formal costs between US$3,162 and US$5,919 higher than the low NPI group and total direct costs between US$10,670 and US$16,141 higher, depending on the severity of cognitive impairments. Models for the entire sample estimated that a one-point increase in the NPI score would result in an annual increase of between US$247 and US$409 in total direct costs, depending on the value of unpaid caregiving.
CONCLUSIONS: Behavioral symptoms in patients with AD significantly increase direct costs of care.

Entities:  

Mesh:

Year:  2002        PMID: 12473759     DOI: 10.1212/01.wnl.0000036904.73393.e4

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  72 in total

Review 1.  Alzheimer's disease: the strength of association of costs with different measures of disease severity.

Authors:  J Mauskopf; J Racketa; E Sherrill
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

Review 2.  Second-generation antipsychotics in dementia: beyond safety concerns. A clinical, systematic review of efficacy data from randomised controlled trials.

Authors:  Salvatore Gentile
Journal:  Psychopharmacology (Berl)       Date:  2010-07-27       Impact factor: 4.530

3.  Protocol for an embedded pragmatic clinical trial to test the effectiveness of Aliviado Dementia Care in improving quality of life for persons living with dementia and their informal caregivers.

Authors:  Alycia A Bristol; Kimberly A Convery; Victor Sotelo; Catherine E Schneider; Shih-Yin Lin; Jason Fletcher; Randall Rupper; James E Galvin; Abraham A Brody
Journal:  Contemp Clin Trials       Date:  2020-04-19       Impact factor: 2.226

Review 4.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

5.  Aggression in persons with dementia: use of nursing theory to guide clinical practice.

Authors:  Diane Dettmore; Ann Kolanowski; Malaz Boustani
Journal:  Geriatr Nurs       Date:  2009 Jan-Feb       Impact factor: 2.361

6.  Medicaid Contributes Substantial Costs to Dementia Care in an Ethnically Diverse Community.

Authors:  Carolyn W Zhu; Katherine A Ornstein; Stephanie Cosentino; Yian Gu; Howard Andrews; Yaakov Stern
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-08-13       Impact factor: 4.077

7.  Management of older adults with dementia who present to emergency services with neuropsychiatric symptoms.

Authors:  Ryan M Silwanowicz; Donovan T Maust; Lisa S Seyfried; Claire Chiang; Claire Stano; Helen C Kales
Journal:  Int J Geriatr Psychiatry       Date:  2016-10-04       Impact factor: 3.485

8.  Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease.

Authors:  Paula T Trzepacz; Jeffrey Cummings; Thomas Konechnik; Tammy D Forrester; Curtis Chang; Ellen B Dennehy; Brian A Willis; Catherine Shuler; Linda B Tabas; Constantine Lyketsos
Journal:  Int Psychogeriatr       Date:  2012-12-21       Impact factor: 3.878

9.  Practice constraints, behavioral problems, and dementia care: primary care physicians' perspectives.

Authors:  Ladson Hinton; Carol E Franz; Geetha Reddy; Yvette Flores; Richard L Kravitz; Judith C Barker
Journal:  J Gen Intern Med       Date:  2007-09-07       Impact factor: 5.128

Review 10.  Assessing neuropsychiatric symptoms in people with dementia: a systematic review of measures.

Authors:  Laura N Gitlin; Katherine A Marx; Ian H Stanley; Bryan R Hansen; Kimberly S Van Haitsma
Journal:  Int Psychogeriatr       Date:  2014-08-06       Impact factor: 3.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.